HM Krumholz
Abstract
The optimal duration of oral anticoagulant therapy after a second episode of venous thromboembolism is unknown. In this multicenter Swedish trial, investigators randomized 227 patients with second episodes of venous thromboembolism to anticoagulant therapy for six months or indefinitely . Oral anticoagulant therapy was given to …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The optimal duration of oral anticoagulant therapy after a second episode of venous thromboembolism is unknown. In this multicenter Swedish trial, investigators randomized 227 patients with second episodes of venous thromboembolism to anticoagulant therapy for six months or indefinitely . Oral anticoagulant therapy was given to …
Key concepts: Medicine, Oral anticoagulant, Anticoagulant therapy, Venous thromboembolism, Anticoagulant, Randomized controlled trial, Duration (music), Warfarin